The study by González et al. [24], who analyzed the ApoE variants in a cohort of individuals with AD in Castilla y León, observed a similar distribution to the results obtained in this work, with a significant frequency of the ε3 allele in both the case group (80.2%) and the control group (79.3%). Here, APOE is linked to Alzheimer disease.